Seattle-based Sana Biotechnology Inc. (Nasdaq: SANA) is losing its research and development lead. In a Thursday filing with ...
The company that is backed by Amgen (AMGN.O) , opens new tab and Japan's SoftBank ... Treasury yields weigh 8:01 PM UTC · Updated ago Autos & Transportationcategory Tesla laying off more than 10% of ...
Novartis plans to cut as many as 680 jobs in development, Sanofi's pipeline reprioritization project will result in layoffs.
April 5 (Reuters) - Boehringer Ingelheim on Thursday said it will lay off some of its U.S. salesforce ... with the same prices as Boehringer and Amgen, whose Amjevita was the first Humira ...
April 4 (Reuters) - Boehringer Ingelheim on Thursday said it will lay off some of its salesforce due ... with the same prices as Boehringer and Amgen, whose Amjevita was the first Humira ...
(Reuters) - Boehringer Ingelheim on Thursday said it will lay off some of its U.S. salesforce due to poor sales ... its biosimilar Hyrimoz with the same prices as Boehringer and Amgen, whose Amjevita ...
(Reuters) - Boehringer Ingelheim on Thursday said it will lay off some of its U.S. salesforce due to poor sales ... its biosimilar Hyrimoz with the same prices as Boehringer and Amgen, whose Amjevita ...
Thompson joins from Amgen, where she was EVP of rare disease ... but Fierce Biotech calculated at least 2,398 people laid off from the 25 companies reporting numbers of employees affected for ...
Even with discounts that reach as high as 86%, Humira biosimilars are finding it difficult to take market share away from the ...
London: Boehringer Ingelheim on Thursday said it will lay off some of its U.S. salesforce ... Hyrimoz with the same prices as Boehringer and Amgen, whose Amjevita was the first Humira biosimilar ...
In a Worker Adjustment and Retraining Notification Act (WARN) notice, BMS said it's laying off 252 staffers at 3545 ... a KRAS inhibitor that's going up against Amgen's Lumakras.
Boehringer Ingelheim on Thursday said it will lay off some of its salesforce due to poor US sales ... Swiss drugmaker Sandoz launched its biosimilar Hyrimoz with the same prices as Boehringer and ...